Within the realm of E. coli expression, the T7 system is the most popular approach for producing recombinant protein. In this system, the target gene is cloned into an expression vector downstream of the T7 promoter and this construct is introduced into a T7 expression host. T7 expression hosts such as DE3 prophage strains or T7 Express strains carry a chromosomal copy of the phage T7 RNA polymerase gene. When inducer is added, T7 RNA polymerase is expressed and becomes dedicated to target gene transcription. T7 expression is often very robust but may suffer from undesirable basal (non-induced) transcription especially in DE3 strains. Regulation of IPTG-induced T7 expression is accomplished by co-expressing the lac repressor from a plasmid or a host-encoded lacI gene and by co-expressing T7 lysozyme, the natural inhibitor of T7 RNA polymerase activity. T7 lysozyme may be expressed from pLysS or pLysE plasmids or a variant T7 lysozyme may be expressed from the lysY gene present within multiple NEB protein expression strains. The lysY gene product lacks amidase (lysozyme) activity against the E. coli cell wall while retaining the ability to inhibit basal T7 RNA polymerase activity.
- What are the strain properties (C2566)?
- Is T7 Express (NEB #C2566H and NEB #C2566I) compatible with auto-induction procedures?
- What are the strain properties (C2527)?
- What is the difference between T7 Express (NEB #C2566H/I) and BL21(DE3) (NEB #C2527H/I)?
- Can the NEBExpress Competent E.coli (High Efficiency) be used for the expression of constructs containing a T7 promoter?
Avoid Common Obstacles in Protein Expression
Read how to avoid common obstacles in protein expression that prevent interactions with cellular machinery.
- Competent Cell Brochure
- Protein Expression & Purification Brochure
- DNA Sequences and Maps Tool
- Competent Cell Product Comparison
- Competent Cell Selection Guide
- Agrawal, A., Bisharyan, Y., Papoyan, A, Bednenko, J., Cardarelli, J., Yao, M., Clark, T., Berkmen, M., Ke, N., Colussi, P. (2019) Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli. Protein Expr Purif; 153, 7-17. PubMedID: 30081196, DOI: 10.1016/j.pep.2018.08.001.
- Leith, E.M., O'Dell, W.B., Ke, N., McClung, C., Berkmen, M., Bergonzo, C., Brinson, R.G., Kelman, Z (2019) Characterization of the internal translation initiation region in monoclonal antibodies expressed in Escherichia coli J Biol Chem; 294(48), 18046-18056.. PubMedID: 31604819, DOI: 10.1074/jbc.RA119.011008
- Reddy, P.T., Brinson, R.G., Hoopes, J.T., McClung, C., Ke, N., Kashi, L. (2018) Platform development for expression and purification of stable isotope labeled monoclonal antibodies in Escherichia coli. mAbs MAbs; 10 (7), 992-1002. PubMedID: 30060704, DOI: 10.1080/19420862.2018.1496879
- Robinson, M.-P., Ke, N., Lobstein, J., Peterson, C., Szkodny, A., Mansell, T.J., Tuckey, C., Riggs, P.D., Colussi, P.A., Noren, C.J., Taron, C.H., Delisa, M.P., Berkmen, M. (2015) Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria Nat Commun; (6)8072, PubMedID: 26311203, DOI: 10.1038/ncomms9072.
E. coli Hosts
This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB).
While NEB develops and validates its products for various applications, the use of this product may require the buyer to obtain additional third party intellectual property rights for certain applications.
For more information about commercial rights, please email us at email@example.com.
This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.